-
公开(公告)号:US07989498B2
公开(公告)日:2011-08-02
申请号:US10671967
申请日:2003-09-25
申请人: Jeffrey O Saunders , Daniel Elbaum , Perry M Novak , Douglas Naegele , Randy S Bethiel , Steven M Ronkin , Michael C Badia , Catharine Frank , Dean P Stamos , William Walters , David Pearlman
发明人: Jeffrey O Saunders , Daniel Elbaum , Perry M Novak , Douglas Naegele , Randy S Bethiel , Steven M Ronkin , Michael C Badia , Catharine Frank , Dean P Stamos , William Walters , David Pearlman
IPC分类号: A61K31/165 , A61K31/16
CPC分类号: C07D213/75 , A61K31/4965 , A61K31/53 , C07C217/84 , C07C235/64 , C07C311/21 , C07C311/29 , C07C317/40 , C07C323/42 , C07C333/08 , C07D263/32 , C07D271/06 , C07D307/91 , C07D317/68 , C07D413/12
摘要: The present invention relates to compounds which inhibit IMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds.
摘要翻译: 本发明涉及抑制IMPDH的化合物。 本发明还涉及包含这些化合物的药物组合物。 本发明的化合物和药物组合物特别适用于抑制IMPDH酶活性,因此可有利地用作IMPDH介导的过程的治疗剂。 本发明还涉及使用本发明化合物和相关化合物抑制IMPDH活性的方法。
-
公开(公告)号:US06653309B1
公开(公告)日:2003-11-25
申请号:US09702991
申请日:2000-10-30
申请人: Jeffrey O. Saunders , Daniel Elbaum , Perry M. Novak , Douglas Naegele , Randy S. Bethiel , Steven M. Ronkin , Michael C. Badia , Catharine Frank , Dean P. Stamos , William Walters , David Pearlman
发明人: Jeffrey O. Saunders , Daniel Elbaum , Perry M. Novak , Douglas Naegele , Randy S. Bethiel , Steven M. Ronkin , Michael C. Badia , Catharine Frank , Dean P. Stamos , William Walters , David Pearlman
IPC分类号: C07D25102
CPC分类号: C07D213/75 , A61K31/4965 , A61K31/53 , C07C217/84 , C07C235/64 , C07C311/21 , C07C311/29 , C07C317/40 , C07C323/42 , C07C333/08 , C07D263/32 , C07D271/06 , C07D307/91 , C07D317/68 , C07D413/12
摘要: The present invention relates to compounds which inhibit IMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well-suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds.
摘要翻译: 本发明涉及抑制IMPDH的化合物。 本发明还涉及包含这些化合物的药物组合物。 本发明的化合物和药物组合物特别适合于抑制IMPDH酶活性,因此可有利地用作IMPDH介导的方法的治疗剂。 本发明还涉及使用本发明化合物和相关化合物抑制IMPDH活性的方法。
-